Back to the main directory
EarningsReview / Equity
- Axactor (Buy, TP: NOK7.00) - Looking to refinance bond by DnB Markets
- Hexagon Purus (Buy, TP: NOK29.00) - Preparing for higher activity by DnB Markets
- Physitrack (Buy, TP: SEK34.00) - At the profitability trough by DnB Markets
- Valuation update by DnB Markets
- Protect this outlook by BNP Paribas Exane
- Itaú BBA on Armac: Heavy Rains Prevented Better Results in 1Q23, as Anticipated by Itau
- Itaú BBA on YDUQS: 1Q23 Figures Drive 9% EBITDA Beat by Itau
- Umicore SA (UMI BB) by HSBC
- Hexagon Purus - Building the foundations, an improving line of sight by Danske Bank Equity Research
- Wynn Macau (1128 HK) by HSBC
- Ence - In-line sector outlook, reassuring message on cash costs by JB Capital Markets
- Prices, volumes, arbitrage opportunities, and implications on company profits by BNP Paribas Exane
- Thoughts ahead of FY 23, we see balanced risk reward by BNP Paribas Exane
- A bird in the hand is worth two in the bush by BNP Paribas Exane
- NII fireworks by BNP Paribas Exane
- Banco BPM - EXCELLENT RESULTS LEADING TO HIGHER LEVEL OF AMBITION by Equita Sim
- RVRC Holding - Solid report that hints at more to come by Danske Bank Equity Research
- Swedish margin risk overplayed by BNP Paribas Exane
- AST Groupe - Un T1 plus dynamique by MidCap Partners
- Bakkafrost - Hold: Scotland improving well, but challenges remain by Nordea
- Revolution Race Holding - Buy/SEK 45: Decent Q3 supports our earnings turnaround view by Nordea
- Hexagon Purus - Buy/NOK 36: A mixed bag creates an attractive entry point by Nordea
- Orkla - Buy/NOK 96 (Hold): Price hikes driving strong sales growth by Nordea
- Sagax - Buy/SEK 290: One of the few with potential for a rating upgrade by Nordea
- Rovi - Better 1Q23 but prospects for 2023 remain weak; reiterating Neutral by JB Capital Markets